CircRNAs as upstream regulators of miRNA//HMGA2 axis in human cancer

被引:2
作者
Sun, Qiqi [1 ]
Lei, Xiaoyong [1 ,2 ]
Yang, Xiaoyan [1 ,2 ]
机构
[1] Univ South China, Hengyang Med Coll, Sch Pharmaceut Sci, 28 Western Changsheng Rd, Hengyang 421001, Hunan, Peoples R China
[2] Univ South China, Hunan Prov Key Lab Tumor Microenvironm Respons Dru, 28 Western Changsheng Rd, Hengyang 421001, Hunan, Peoples R China
关键词
cancer; circRNA; HMGA2; miRNA; HEPATOCELLULAR-CARCINOMA PROGRESSION; CIRCULAR RNA; DRUG-RESISTANCE; BREAST-CANCER; HMGA2; PROLIFERATION; PROMOTES; MECHANISMS; METASTASIS; APOPTOSIS;
D O I
10.1016/j.pharmthera.2024.108711
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
High mobility group protein A2 (HMGA2) is widely recognized as a chromatin-binding protein, whose overexpression is observed in nearly all human cancers. It exerts its oncogenic effects by influencing various cellular processes such as the epithelial-mesenchymal transition, cell differentiation, and DNA damage repair. MicroRNA (miRNA) serves as a pivotal gene expression regulator, concurrently modulating multiple genes implicated in cancer progression, including HMGA2. It also serves as a significant biomarker for cancer. Circular RNA (circRNA) plays a crucial role in gene regulation primarily by sequestering miRNAs and impeding their ability to enhance the expression of other genes, including HMGA2. Increasingly, studies have underscored the vital role of miRNA/HMGA2 interactions in cancer. Given the significance of circRNA as an upstream regulatory mediator and the complexity of regulatory mechanisms, we hereby present a comprehensive overview of the pivotal role of circRNAs as upstream regulators of the miRNA//HMGA2 axis in human cancers. This insight may herald a novel direction for future cancer research. (c) 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] The emerging role and mechanism of HMGA2 in breast cancer
    Ma, Qing
    Ye, Sisi
    Liu, Hong
    Zhao, Yu
    Zhang, Wei
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (05)
  • [2] HMGA2 as a Critical Regulator in Cancer Development
    Mansoori, Behzad
    Mohammadi, Ali
    Ditzel, Henrik J.
    Duijf, Pascal H. G.
    Khaze, Vahid
    Gjerstorff, Morten F.
    Baradaran, Behzad
    GENES, 2021, 12 (02) : 1 - 23
  • [3] HMGA2 regulates lung cancer proliferation and metastasis
    Gao, Xiaotian
    Dai, Ming
    Li, Qinglan
    Wang, Zhigang
    Lu, Yonglin
    Song, Zeqing
    THORACIC CANCER, 2017, 8 (05) : 501 - 510
  • [4] circUBAP2 regulates osteosarcoma progression via the miR-204-3p/HMGA2 axis
    Ma, Weiguo
    Xue, Ning
    Zhang, Junhua
    Wang, Dan
    Yao, Xiaobin
    Lin, Lin
    Xu, Qingxia
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2021, 58 (03) : 298 - 311
  • [5] Circular RNA 100146 Promotes Colorectal Cancer Progression by the MicroRNA 149/HMGA2 Axis
    Liu, Kunpeng
    Mou, Yuhua
    Shi, Xiufang
    Liu, Tingkun
    Chen, Zhanfeng
    Zuo, Xingmei
    MOLECULAR AND CELLULAR BIOLOGY, 2021, 41 (02)
  • [6] Expression and significances of MiRNA Let-7 and HMGA2 in laryngeal carcinoma
    Song, F. -C.
    Yang, Y.
    Liu, J. -X.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2016, 20 (21) : 4452 - 4458
  • [7] miRNA-101 Suppresses Epithelial-to-mesenchymal Transition by Targeting HMGA2 in Pancreatic Cancer Cells
    Jiang, Wenli
    Gu, Wen
    Qiu, Ronglin
    He, Songbing
    Shen, Chenglong
    Wu, Yaohao
    Zhang, Jie
    Zhou, Jiajia
    Guo, Yixing
    Wan, Daiwei
    Li, Zhixi
    Deng, Jiemin
    Zeng, Lexiang
    Tang, Jin
    Zhou, Jin
    Zhi, Qiaoming
    Deng, Xiaogeng
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2016, 16 (04) : 432 - 439
  • [8] Has_circ_0048764 promotes breast cancer progression by sponging miR-578 and regulating HMGA2 expression
    Ding, Mingjian
    Dai, Dianlu
    Yang, Wenhua
    Geng, Cuizhi
    Cui, Guozhong
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2023, 42 (06) : 448 - 463
  • [9] HMGA2 promotes cancer metastasis by regulating epithelial-mesenchymal transition
    Ma, Qing
    Ye, Sisi
    Liu, Hong
    Zhao, Yu
    Mao, Yan
    Zhang, Wei
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [10] Silencing of HMGA2 by siRNA Loaded Methotrexate Functionalized Polyamidoamine Dendrimer for Human Breast Cancer Cell Therapy
    Gaballu, Fereydoon Abedi
    Cho, William Chi-Shing
    Dehghan, Gholamreza
    Zarebkohan, Amir
    Baradaran, Behzad
    Mansoori, Behzad
    Abbaspour-Ravasjani, Soheil
    Mohammadi, Ali
    Sheibani, Nader
    Aghanejad, Ayuob
    Dolatabadi, Jafar Ezzati Nazhad
    GENES, 2021, 12 (07)